[HTML][HTML] Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics …

JM Carrascosa, N Rivera, I Garcia-Doval… - Actas Dermo …, 2015 - Elsevier
Background With the advent of biologic drugs in the management of moderate to severe
psoriasis, there may have been a shift in therapeutic approach from rotational strategies to a …

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases …

JM Carrascosa, N Rivera… - … dermo-sifiliogr.(Ed …, 2015 - pesquisa.bvsalud.org
BACKGROUND: With the advent of biologic drugs in the management of moderate to severe
psoriasis, there may have been a shift in therapeutic approach from rotational strategies to a …

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases …

JM Carrascosa, N Rivera… - Actas dermo …, 2015 - pubmed.ncbi.nlm.nih.gov
Background With the advent of biologic drugs in the management of moderate to severe
psoriasis, there may have been a shift in therapeutic approach from rotational strategies to a …

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases …

JM Carrascosa, N Rivera, I Garcia-Doval… - Actas Dermo …, 2015 - infona.pl
With the advent of biologic drugs in the management of moderate to severe psoriasis, there
may have been a shift in therapeutic approach from rotational strategies to a unidirectional …

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases …

JM Carrascosa, N Rivera, I Garcia-Doval… - Actas Dermo …, 2015 - europepmc.org
Background With the advent of biologic drugs in the management of moderate to severe
psoriasis, there may have been a shift in therapeutic approach from rotational strategies to a …

[引用][C] Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics …

JM Carrascosa, N Rivera… - Actas Dermo …, 2015 - produccioncientifica.ucm.es
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up?
The percentage of patients with severe psoriasis on biologics increases over time …

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases …

JM Carrascosa, N Rivera, I Garcia-Doval… - Actas dermo …, 2015 - portalrecerca.uab.cat
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The
percentage of patients with severe psoriasis on biologics increases over time — Universitat …

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases …

JM Carrascosa, N Rivera, I Garcia-Doval… - Actas Dermo …, 2015 - Elsevier
Background With the advent of biologic drugs in the management of moderate to severe
psoriasis, there may have been a shift in therapeutic approach from rotational strategies to a …

[引用][C] Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics …

JM Carrascosa, N Rivera… - Actas dermo …, 2015 - produccioncientifica.ucm.es
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up?
The percentage of patients with severe psoriasis on biologics increases over time …

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases …

JM Carrascosa, N Rivera… - … dermo-sifiliogr.(Ed …, 2015 - pesquisa.bvsalud.org
BACKGROUND: With the advent of biologic drugs in the management of moderate to severe
psoriasis, there may have been a shift in therapeutic approach from rotational strategies to a …